Home
News
News archive
Diamond Information


home > news FDA approves new option for cancer patients

FDA approves new option for cancer patients




Vitrakvi is the first medication developed specifically to target tumors based on gene mutations, not their location in the body.



Click Here to read the entire article...



Find this article in Google